Work

Ceritinib (Zykadia®) as first-line therapy for patients with advanced ALK-positive non-small cell lung cancer

Year: 2017
Type: article
Language: English
Field: Medicine
Open Access status: closed
OpenAlex ID: W2724339965
FWCI: 0.206
Cites:
Cited by: 1
Related to: 10